Investors Press Releases Cardiol Therapeutics Announces Clinical Steering Committee for Phase 2 International Trial in Acute Myocarditis Using CardiolRx™100 November 19, 2019 Cardiol Therapeutics Announces Completion of Manufacturing Scale-up for Commercialization of CardiolRx™100 October 01, 2019 Cardiol Therapeutics to Webcast Live at VirtualInvestorConferences.com on September 12th September 05, 2019 Cardiol Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference July 29, 2019 Cardiol Therapeutics Announces Plans for Orphan Drug Program in Acute Myocarditis with CardiolRx CBD Formulation June 20, 2019 Cardiol Therapeutics Reports 2018 AGM Results June 13, 2019 Cardiol Therapeutics to Webcast Annual General Meeting on June 12 June 10, 2019 Cardiol Therapeutics’ Pharmaceutical Partner Noramco Presents at U.S. FDA Public Hearing on CBD June 03, 2019 Cardiol Therapeutics Commences Trading on the OTCQX May 30, 2019 Cardiol Therapeutics Announces Filing of Year-End Financial Statements and MD&A March 28, 2019 Page 3 of 6«12345...»Last »
